Literature DB >> 25491505

A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.

Sarah G J A Peeters1, Catharina M L Zegers2, Natasja G Lieuwes2, Wouter van Elmpt2, Jonas Eriksson3, Guus A M S van Dongen3, Ludwig Dubois2, Philippe Lambin2.   

Abstract

PURPOSE: Several individual clinical and preclinical studies have shown the possibility of evaluating tumor hypoxia by using noninvasive positron emission tomography (PET). The current study compared 3 hypoxia PET tracers frequently used in the clinic, [(18)F]FMISO, [(18)F]FAZA, and [(18)F]HX4, in a preclinical tumor model. Tracer uptake was evaluated for the optimal time point for imaging, tumor-to-blood ratios (TBR), spatial reproducibility, and sensitivity to oxygen modification. METHODS AND MATERIALS: PET/computed tomography (CT) images of rhabdomyosarcoma R1-bearing WAG/Rij rats were acquired at multiple time points post injection (p.i.) with one of the hypoxia tracers. TBR values were calculated, and reproducibility was investigated by voxel-to-voxel analysis, represented as correlation coefficients (R) or Dice similarity coefficient of the high-uptake volume. Tumor oxygen modifications were induced by exposure to either carbogen/nicotinamide treatment or 7% oxygen breathing.
RESULTS: TBR was stabilized and maximal at 2 hours p.i. for [(18)F]FAZA (4.0 ± 0.5) and at 3 hours p.i. for [(18)F]HX4 (7.2 ± 0.7), whereas [(18)F]FMISO showed a constant increasing TBR (9.0 ± 0.8 at 6 hours p.i.). High spatial reproducibility was observed by voxel-to-voxel comparisons and Dice similarity coefficient calculations on the 30% highest uptake volume for both [(18)F]FMISO (R = 0.86; Dice coefficient = 0.76) and [(18)F]HX4 (R = 0.76; Dice coefficient = 0.70), whereas [(18)F]FAZA was less reproducible (R = 0.52; Dice coefficient = 0.49). Modifying the hypoxic fraction resulted in enhanced mean standardized uptake values for both [(18)F]HX4 and [(18)F]FAZA upon 7% oxygen breathing. Only [(18)F]FMISO uptake was found to be reversible upon exposure to nicotinamide and carbogen.
CONCLUSIONS: This study indicates that each tracer has its own strengths and, depending on the question to be answered, a different tracer can be put forward.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491505     DOI: 10.1016/j.ijrobp.2014.09.045

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  51 in total

1.  Clostridium to treat cancer: dream or reality?

Authors:  Jan Theys; Philippe Lambin
Journal:  Ann Transl Med       Date:  2015-05

2.  In vitro simultaneous mapping of the partial pressure of oxygen, pH and inorganic phosphate using electron paramagnetic resonance.

Authors:  Akihiro Taguchi; Stephen DeVience; Benoit Driesschaert; Valery V Khramtsov; Hiroshi Hirata
Journal:  Analyst       Date:  2020-03-05       Impact factor: 4.616

Review 3.  Personalized radiotherapy treatment planning based on functional imaging.

Authors:  Malgorzata Skórska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-15

4.  Oxygen-Guided Radiation Therapy.

Authors:  Boris Epel; Matthew C Maggio; Eugene D Barth; Richard C Miller; Charles A Pelizzari; Martyna Krzykawska-Serda; Subramanian V Sundramoorthy; Bulent Aydogan; Ralph R Weichselbaum; Victor M Tormyshev; Howard J Halpern
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-08       Impact factor: 7.038

Review 5.  Biological validation of electron paramagnetic resonance (EPR) image oxygen thresholds in tissue.

Authors:  Inna Gertsenshteyn; Mihai Giurcanu; Peter Vaupel; Howard Halpern
Journal:  J Physiol       Date:  2020-06-28       Impact factor: 5.182

Review 6.  Molecular imaging of hypoxia in non-small-cell lung cancer.

Authors:  Connie Yip; Philip J Blower; Vicky Goh; David B Landau; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-21       Impact factor: 9.236

Review 7.  Validation of functional imaging as a biomarker for radiation treatment response.

Authors:  C Jentsch; B Beuthien-Baumann; E G C Troost; G Shakirin
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

Review 8.  Magnetic resonance imaging in precision radiation therapy for lung cancer.

Authors:  Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald
Journal:  Transl Lung Cancer Res       Date:  2017-12

9.  Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.

Authors:  Daniel Coman; Julius Chapiro; Lynn Jeanette Savic; Isabel Theresa Schobert; Dana Peters; John J Walsh; Fabian Max Laage-Gaupp; Charlie Alexander Hamm; Nina Tritz; Luzie A Doemel; MingDe Lin; Albert Sinusas; Todd Schlachter; James S Duncan; Fahmeed Hyder
Journal:  Clin Cancer Res       Date:  2019-10-03       Impact factor: 12.531

Review 10.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.